Felix C A, Lange B J
Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania 19104-4318, USA.
Oncologist. 1999;4(3):225-40.
Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in infants have in common a high incidence of translocations of the MLL gene at chromosome band 11q23. Similar translocations occur in leukemias associated with chemotherapies that target DNA topoisomerase II. MLL has numerous different partner genes. The role of the many MLL fusion proteins in leukemogenesis is not yet understood. The t(4;11) translocation, the most common translocation in infant ALL, adversely affects the outcome. Additional genetic changes, especially Ikaros alterations, are found in infant ALL. Other forms of myeloid leukemia in infants present as myelodysplastic and myeloproliferative syndromes, which may be associated with constitutional disorders. This review will consider all leukemia in infants, but will focus on leukemias with MLL gene translocations.
婴儿急性淋巴细胞白血病(ALL)和急性髓细胞白血病(AML)的共同特点是11号染色体q23带的MLL基因易位发生率很高。类似的易位也出现在与靶向DNA拓扑异构酶II的化疗相关的白血病中。MLL有许多不同的伙伴基因。众多MLL融合蛋白在白血病发生中的作用尚不清楚。t(4;11)易位是婴儿ALL中最常见的易位,对预后有不利影响。在婴儿ALL中还发现了其他基因变化,尤其是IKAROS改变。婴儿的其他形式的髓细胞白血病表现为骨髓增生异常和骨髓增殖综合征,可能与先天性疾病有关。本综述将考虑婴儿的所有白血病,但将重点关注伴有MLL基因易位的白血病。